Nabil Saba

Nabil Saba

Emory University - Atlanta / United States
Others
AD Scientific Index ID: 1337383
person_outline Nabil Saba's MOST POPULAR ARTICLES
1-) Nivolumab for recurrent squamous-cell carcinoma of the head and neckRL Ferris, G Blumenschein Jr, J Fayette, J Guigay, AD Colevas, L Licitra, ...N Engl J Med 375, 1856-1867, 201636172016
2-) Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by …RL Ferris, G Blumenschein Jr, J Fayette, J Guigay, AD Colevas, L Licitra, ...Oral oncology 81, 45-51, 20186372018
3-) An update on larynx cancerCE Steuer, M El‐Deiry, JR Parks, KA Higgins, NF SabaCA: a cancer journal for clinicians 67 (1), 31-50, 20176412017
4-) Pembrolizumab for platinum-and cetuximab-refractory head and neck cancer: results from a single-arm, phase II studyJ Bauml, TY Seiwert, DG Pfister, F Worden, SV Liu, J Gilbert, NF Saba, ...Journal of Clinical Oncology 35 (14), 1542-1549, 20176972017
5-) Sickle blood contains tissue factor–positive microparticles derived from endothelial cells and monocytesAS Shet, O Aras, K Gupta, MJ Hass, DJ Rausch, N Saba, L Koopmeiners, ...Blood 102 (7), 2678-2683, 20036672003